CompletedNot Applicable

Ambu AuraGain vs LMA Supreme in Laparoscopic Surgery

Spain60 participantsStarted 2015-06

Plain-language summary

The aim of the study is to compare the performance of two supraglottic airway devices (SGA), the new Ambu AuraGain and the LMA Supreme, in sixty female patients undergoing gynaecologic laparoscopy in the trendelemburg position. Primary outcome is the airway seal pressure. Secondary outcomes are ease of insertion, quality of ventilation, endoscopic view of the glottis, gastric tube passage and complications.

Who can participate

Age range18 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients evaluated as eligible for a SGA * ASA I-III * Without criteria for difficult airway * Body Mass Index ≤ 35 kg/m2 * The patient has signed the Informed Consent * The patient understands his or hers rights and consequences related to this investigation Exclusion Criteria: * Planned operation time \> 2 hours * High risk of regurgitation * Respiratory tract pathology * Preoperative sore throat * Patients with a known or predicted difficult airway * Patients diagnosed with dementia or any mental handicaps * Patient who has a guardian.

What they're measuring

Airway seal pressure

Timeframe: At 15 minutes

Trial details

NCT IDNCT02511652

SponsorHospital Clinic of Barcelona

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-12

View on ClinicalTrials.gov More Laparoscopy trials